Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v5-EN
Language French English
Date Updated 2023-10-04 2023-10-04
Drug Identification Number 02312557 02312557
Brand name BOOSTRIX-POLIO BOOSTRIX-POLIO
Common or Proper name Combined diphtheria, tetanus, acellular pertussis (adsorbed) and inactivated poliomyelitis vaccine Combined diphtheria, tetanus, acellular pertussis (adsorbed) and inactivated poliomyelitis vaccine
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients INACTIVATED POLIOVIRUS TYPE III INACTIVATED POLIOVIRUS TYPE II INACTIVATED POLIOVIRUS TYPE I PERTACTIN ADSORBED FILAMENTOUS HAEMAGGLUTININ ADSORBED PERTUSSIS TOXOID ADSORBED TETANUS TOXOID ADSORBED DIPHTHERIA TOXOID ADSORBED INACTIVATED POLIOVIRUS TYPE III INACTIVATED POLIOVIRUS TYPE II INACTIVATED POLIOVIRUS TYPE I PERTACTIN ADSORBED FILAMENTOUS HAEMAGGLUTININ ADSORBED PERTUSSIS TOXOID ADSORBED TETANUS TOXOID ADSORBED DIPHTHERIA TOXOID ADSORBED
Strength(s) 32D 8D 40D 2.5MCG 8MCG 8MCG 5.0LF 2.5LF 32D 8D 40D 2.5MCG 8MCG 8MCG 5.0LF 2.5LF
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR INTRAMUSCULAR
Packaging size 10's 10's
ATC code J07CA J07CA
ATC description BACTERIAL AND VIRAL VACCINES, COMBINED BACTERIAL AND VIRAL VACCINES, COMBINED
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2023-06-20 2023-06-20
Estimated end date 2023-10-18 2023-10-18
Actual end date 2023-10-02 2023-10-02
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Supply unavailable Supply unavailable
Health Canada comments